
-
2007
Company Description
Epizyme is a biopharmaceutical company focusing on treatments for blood cancer and tumors.
Epizyme is a biopharmaceutical company located in Cambridge, MA, that is focused on researching treatments for blood cancer and tumors. Founded in late 2007, the company has brought together premier academic and industry leaders to rapidly translate the exciting discoveries emerging from epigenetic research into specific programs that will produce important, novel, molecularly targeted drugs of the future.
-
Manufacturer:
Science and Engineering -
Formed:
2007 -
Company Website:
-
Company E-mail:
-
Company Address:
400 Technology SquareCambridge, MAUnited States -
CEO:
- Robert A. Copeland
-
We recognize our sponsors starting at $1 per entry.
Learn more at https://www.ithistory.org/benefits